Hepatoprotective effects of antioxidants in chronic hepatitis C

World Journal of Gastroenterology

Volumn 16, Issue 15, 2010, Pages 1937-1938

  Moreno Otero, Ricardo ^a   Trapero Marugán, María ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Antioxidant; Chronic hepatitis C; N acetyl cysteine; Nitric oxide; Resveratrol; S adenosyl methionine

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; RESVERATROL; S ADENOSYLMETHIONINE;

ALCOHOL LIVER CIRRHOSIS; CHRONIC LIVER DISEASE; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION PREVENTION; INSULIN RESISTANCE; LETTER; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER ISCHEMIA; LIVER PROTECTION; NITROSATIVE STRESS; OXIDATIVE STRESS; PROTEIN EXPRESSION; REPERFUSION INJURY; STEATOSIS; VIRUS PATHOGENESIS;

EID: 77951435300     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i15.1937     Document Type: Letter

References (11)

1. Nakamura M, Saito H, Ikeda M, Hokari R, Kato N, Hibi T, Miura S. An antioxidant resveratrol significantly enhanced replication of hepatitis C virus. World J Gastroenterol 2010; 16: 184-192
2. Vidali M, Tripodi MF, Ivaldi A, Zampino R, Occhino G, Restivo L, Sutti S, Marrone A, Ruggiero G, Albano E, Adinolfi LE. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol 2008; 48: 399-406
3. Melhem A, Stern M, Shibolet O, Israeli E, Ackerman Z, Pappo O, Hemed N, Rowe M, Ohana H, Zabrecky G, Cohen R, Ilan Y. Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroenterol 2005; 39: 737-742
4. Medina J, Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs 2005; 65: 2445-2461
5. García-Monzón C, Majano PL, Zubia I, Sanz P, Apolinario A, Moreno-Otero R. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol 2000; 32: 331-338
6. Sanz-Cameno P, Medina J, García-Buey L, García-Sánchez A, Borque MJ, Martín-Vílchez S, Gamallo C, Jones EA, Moreno-Otero R. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol 2002; 37: 723-729
7. Romero M, García-Monzón C, Clemente G, Salcedo M, Alvarez E, Majano PL, Moreno-Otero R. Intrahepatic expression of inducible nitric oxide synthase in acute liver allograft rejection: evidence of modulation by corticosteroids. Liver Transpl 2001; 7: 16-21
8. Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl 2005; 11: 1031-1047
9. Majano PL, Medina J, Zubía I, Sunyer L, Lara-Pezzi E, Maldonado-Rodríguez A, López-Cabrera M, Moreno-Otero R. N-Acetyl-cysteine modulates inducible nitric oxide synthase gene expression in human hepatocytes. J Hepatol 2004; 40: 632-637
10. Mato JM, Cámara J, Fernández de Paz J, Caballería L, Coll S, Caballero A, García-Buey L, Beltrán J, Benita V, Caballería J, Solà R, Moreno-Otero R, Barrao F, Martín-Duce A, Correa JA, Parés A, Barrao E, García-Magaz I, Puerta JL, Moreno J, Boissard G, Ortiz P, Rodés J. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 1999; 30: 1081-1089
11. Majano PL, García-Monzón C, García-Trevijano ER, Corrales FJ, Cámara J, Ortiz P, Mato JM, Avila MA, Moreno-Otero R. S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes. J Hepatol 2001; 35: 692-699